| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 15,521 | 15,129 | 15,166 | 15,249 | | Cost of Revenue | 2,385 | 2,730 | 3,179 | 3,488 | | | Gross Profit | 13,136 | 12,399 | 11,987 | 11,761 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,205 | 7,678 | 7,595 | 7,736 | | Non Recurring |
-
|
-
|
-
| 2,580 | | Others | 1,338 | 1,018 | 591 | (2,593) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,593 | 3,703 | 3,801 | 4,038 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 3,593 | 3,703 | 3,801 | 4,038 | | Interest Expense | 1,198 | 1,221 | 1,199 | 1,132 | | Income Before Tax | 2,395 | 2,482 | 2,602 | 2,906 | | Income Tax Expense | 662 | 826 | 838 | 787 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,733 | 1,656 | 1,764 | 2,119 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,733 | 1,656 | 1,764 | 2,119 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,733 | $1,656 | $1,764 | $2,119 |
|
0.39% Nasdaq 
Income Statement
